Corporate Philanthropy

We would like to thank our Corporate Partner

Otolith Labs

Otolith Labs is pioneering the first medical wearable for the treatment of chronic vertigo. The device, which is currently conducting clinical trials, has been given Breakthrough Device Designation from the FDA for the indication of treatment of chronic vestibulogenic vertigo in adults.

strengthen customer and employee loyalty

Partnering with VeDA will have a positive influence on your customers and employees. According to leading research:*

  • 92 percent of Americans have a more positive image of companies that support a cause.
  • 87 percent of Americans are likely to switch brands (when price and quality are equal) to support a cause.
  • 88 percent of workers whose employer has a cause-related program feel proud of their company’s values.
  • 93 percent of Americans say it is important for their employer to provide them with opportunities to become involved in social issues.
  • 81 percent of Americans consider a company’s social commitment when deciding where to work.
  • 89 percent of Americans believe that corporations and non-profits should work together to raise money and awareness for causes.

* Cone Research Study, 2007

Sponsorship Policies

To further our mission, VeDA accepts advertising and sponsorship under strict guidelines. We will refuse any advertisement that we believe is incompatible with our mission. The presence of an ad on our site or in one of our newsletters does not imply endorsement of the advertised company or product. Advertisers and sponsors must not make unsubstantiated health claims or suggest VeDA has endorsed a product.

VeDA maintains a distinct separation between advertising content and editorial content. All advertising content on VeDA’s website or in one of our newsletters is clearly labeled as an advertisement. Sponsored areas of the site are labeled as such, and the sponsoring organizations are identified.